This online, on-demand virtual symposium brings together renowned experts in neovascular retinal diseases, including nAMD and DME. In this educational program, these experts use a case-based format to discuss the latest data regarding effective management of these disorders, share their...

Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...

This video-based program is designed for eye care professionals to explore the diagnosis and potential treatment of patients with X-linked retinitis pigmentosa (XLRP) through a unique perspective, putting the patient’s voice front and center. A patient will lend his expertise...

Nearly half the population older than 60 years has more than 1.0 diopter of keratometric astigmatism. With the emergence of more advanced intraocular lenses (IOLs) and surgical technologies, corneal astigmatism management has become an important treatment goal in modern cataract...

Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...

Neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) are significant drivers of vision loss in the United States, and they put substantial burdens on patients—both from the disease itself and the need for regular...

This online, on-demand virtual symposium brings together renowned experts in glaucoma. In this educational program, these experts focus on interventional glaucoma, a more proactive management approach that aims to minimize the challenges associated with topical glaucoma management with the earlier...